Company / Net Debt per Share
Akebia Therapeutics, Inc. Net Debt per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
-$0.61
FY2025
5-year range
-$1.54 / -$0.04
FY2021-FY2025
Trend
-797.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Net Debt per Share changed -797% YoY in FY2025, a notable deviation from the 6-year average annual change of -321%.
Based on SEC 10-K filings.
-0.61 in FY2025.
Improved from $-0.04 to $-0.61 over the past 2 years.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, net debt per share decreased 797.1% year-over-year.
- Peak net debt per share was recorded in FY2019.
- Lowest net debt per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -2.76 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.61 | -797.1% |
| FY2024 | -$0.07 | -51.3% |
| FY2023 | -$0.04 | +67.5% |
| FY2022 | -$0.14 | +91.1% |
| FY2021 | -$1.54 | -268.0% |
| FY2020 | -$0.42 | -968.5% |
| FY2019 | $0.05 | - |
| FY2018 | - | - |
| FY2015 | - | - |
| FY2014 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026